Banner Congress EUSAAT 2012

ETS-EUSAAT joint afternoon symposium

Innovations and applications of the embryonic stem cell test (EST)

Wednesday, September 5th, 2012 - 14:00-18:00


Chairs: Aldert Piersma (ETS), Horst Spielmann (EUSAAT)
14:00-14:30 Horst Spielmann*, FU Berlin, DE
Historic perspective of the EST (embryonic stem cell test) assay
14:30-15:00 Aldert Piersma*, RIVM, NL
Embryonic Stem Cell approaches towards biomarkers of embryotoxicity
15:00-15:30 Peter Theunissen*, Aldert Piersma, RIVM, NL
Development of the neural embryonic stem cell test (ESTn): a model for screening (neuro)developmental toxicity
15:30-16:00 Christian Riebeling, Andreas Luch, Andrea Seiler*, BfR, DE
The validated embryonic stem cell test (EST) and its applicability domain
16:00-16:30 Coffee break
16:30-17:00 Agapios Sachinidis*, University Cologne, DE
Identification of thalidomide-specific transcriptomic and proteomics signatures during differentiation of human embryonic stem cells
17:00-17:30 Tom Knudsen*, EPA, US
Simulating developmental toxicity in a virtual embryo
17:30-18:00 Claudia McGinnis*, Roche Basel, CH
High Throughput Design in industry: Novel automation approaches for improved predictivity in early safety assessment
 18:00 Closing remarks
   * lecturer